What is the recommended intramuscular (IM) administration regimen for vitamin B12 (cyanocobalamin) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin B12 Intramuscular Administration Regimen

For vitamin B12 deficiency, the recommended intramuscular administration regimen is hydroxocobalamin 1 mg intramuscularly three times a week for 2 weeks for patients without neurological involvement, followed by maintenance treatment of 1 mg intramuscularly every 2-3 months lifelong. 1, 2

Initial Treatment Based on Clinical Presentation

With Neurological Involvement

  • Administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement is observed 1, 2
  • Seek urgent specialist advice from neurologist and hematologist for patients with unexplained sensory, motor, or gait symptoms 1
  • After clinical improvement, transition to maintenance therapy 2

Without Neurological Involvement

  • Administer hydroxocobalamin 1 mg intramuscularly three times a week for 2 weeks 1, 2
  • This loading dose ensures rapid replenishment of vitamin B12 stores 3

Maintenance Therapy

  • After initial treatment, provide maintenance therapy with hydroxocobalamin 1 mg intramuscularly every 2-3 months lifelong 1, 2
  • For patients with ileal resection of more than 20 cm, a more frequent regimen of 1000 μg monthly is recommended 1, 2
  • Never discontinue B12 supplementation even if levels normalize, as patients with malabsorption will require lifelong therapy 2

Special Populations

Post-Bariatric Surgery

  • Patients who have undergone bariatric surgery affecting the ileum require regular vitamin B12 injections 1, 2
  • Monthly administration of 1000 μg is often necessary for these patients 2

Inflammatory Bowel Disease

  • Patients with Crohn's disease who have had more than 20 cm of distal ileum resected should receive 1000 μg of vitamin B12 prophylactically every month indefinitely 1
  • Patients with ileal Crohn's disease involving more than 30-60 cm are at risk for B12 deficiency even without resection 1

Cancer Patients

  • For cancer patients with vitamin B12 deficiency, cyanocobalamin 1000 μg can be administered intramuscularly daily for days 1-10, then monthly 1

Monitoring

  • Check serum B12 levels and homocysteine every 3 months until stabilization, then once yearly 2
  • Monitor for neurological symptoms such as paresthesias, gait disturbances, or cognitive changes 2
  • Consider increasing frequency of injections if symptoms recur 3

Important Considerations

  • Never administer folic acid before treating vitamin B12 deficiency, as it may mask underlying B12 deficiency and precipitate subacute combined degeneration of the spinal cord 1
  • Cyanocobalamin should not be given intravenously as there is little opportunity for liver storage resulting from rapid excretion into the urine 1
  • FDA-approved cyanocobalamin injections are available in 1000 μg/mL concentration for intramuscular or subcutaneous use 4

Alternative Approaches

  • While high-dose oral vitamin B12 (1000-2000 μg daily) has shown efficacy in some studies 5, 6, 7, intramuscular therapy remains the standard of care for patients with malabsorption issues 2, 3
  • Intramuscular therapy leads to more rapid improvement and should be considered in patients with severe deficiency or severe neurologic symptoms 7
  • Recent research suggests that up to 50% of individuals may require individualized injection regimens with more frequent administration (ranging from daily or twice weekly to every 2-4 weeks) to remain symptom-free 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vitamin B12 Injection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study.

The American journal of clinical nutrition, 2024

Research

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency.

The Cochrane database of systematic reviews, 2005

Research

Vitamin B12 Deficiency: Recognition and Management.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.